ONWD Onward Medical N.V.
Onward Medical N.V., a medical technology company, develops and commercializes therapies to enable functional recovery for people with spinal cord injury (SCI) in the United States, Europe, and internationally. The company offers ARCEX System, an external stimulator that is intended to improve hand strength and sensation following SCI; ARCIM System, an implantable system currently used to explore potential indications in clinical feasibility studies; ARCBCI System, an implantable system currently being investigated to enable thought driven movement of the legs and upper extremities. Onward Medical N.V. was founded in 2014 and is headquartered in Eindhoven, Netherlands.…
Industry Peers
BiotechnologyKey Statistics
About Onward Medical (EBR: ONWD)
›
Onward Medical (EBR: ONWD) is listed on Euronext Brussels, where its shares trade in EUR. It belongs to the Biotechnology industry, part of the Healthcare sector, and reports about 137 employees.
The shares were at 1.390 EUR on 20 November 2026, down 65.0% over 52 weeks. Its 52-week range is 1.352 EUR to 4.790 EUR: the price is 71.0% below the high and 2.8% above the low.
Its market capitalisation is 96.65M EUR.
Onward Medical reports return on equity of -75.5% and revenue up 253.8% year over year.
It holds more cash than debt, a net cash position of 67.72M EUR. Its Piotroski F-score is 3 out of 9, a weak reading of its financial health. The next earnings report is expected on 30 March 2027.